Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertension

被引:14
作者
Arwood, Meghan J. [1 ]
Vahabi, Nasim [1 ]
Lteif, Christelle [1 ]
Sharma, Ravindra K. [2 ]
Machado, Roberto F. [3 ]
Duarte, Julio D. [1 ]
机构
[1] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA
[2] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL USA
[3] Indiana Univ, Dept Med, Div Pulm Crit Care Sleep & Occupat Med, Indianapolis, IN 46204 USA
关键词
PRESERVED EJECTION FRACTION; HEART-FAILURE; ARTERIAL-HYPERTENSION; GENE-EXPRESSION; PROTEINS; GROWTH; PROLIFERATION; MITOCHONDRIAL; DYSFUNCTION; APOPTOSIS;
D O I
10.1038/s41598-019-55700-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Heart failure with preserved ejection fraction (HFpEF) patients who develop pulmonary hypertension (PH) have an increased risk of death, with combined pre- and post-capillary PH (CpcPH) having the highest risk. However, the mechanism behind PH development in HFpEF is poorly understood. We aimed to identify transcriptomic associations with PH development in HFpEF. Blood was collected from 30 HFpEF patients: 10 without PH, 10 with isolated post-capillary PH, and 10 with CpcPH. Gene expression measurements were completed using transcriptome-wide RNA sequencing. Gene expression differences were compared using a quasi-likelihood method adjusting for age, sex, race, and smoking-status. Biological pathways were compared using global gene expression differences. A replication in 34 additional heart failure patients and a validation in lung tissue from a representative mouse model were completed using quantitative PCR. Six differentially expressed genes were identified when comparing transcriptomics between subjects with CpcPH and those without PH. When tested in additional subjects, only the association with ID2 replicated. Consistent with clinical findings, Id2 expression was also upregulated in mice with HFpEF and PH. Pathway analysis identified proliferative and mitochondrial pathways associated with CpcPH. Thus, these patients may possess systemic pathophysiological differences similar to those observed in pulmonary arterial hypertension patients.
引用
收藏
页数:10
相关论文
共 61 条
[1]   Acquired Mitochondrial Abnormalities, Including Epigenetic Inhibition of Superoxide Dismutase 2, in Pulmonary Hypertension and Cancer: Therapeutic Implications [J].
Archer, Stephen L. .
HYPOXIA: TRANSLATION IN PROGRESS, 2016, 903 :29-53
[2]   Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension [J].
Assad, Tufik R. ;
Hemnes, Anna R. ;
Larkin, Emma K. ;
Glazer, Andrew M. ;
Xu, Meng ;
Wells, Quinn S. ;
Farber-Eger, Eric H. ;
Sheng, Quanhu ;
Shyr, Yu ;
Harrell, Frank E. ;
Newman, John H. ;
Brittain, Evan L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (23) :2525-2536
[3]   Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension [J].
Assad, Tufik R. ;
Brittain, Evan L. ;
Wells, Quinn S. ;
Farber-Eger, Eric H. ;
Halliday, Stephen J. ;
Doss, Laura N. ;
Xu, Meng ;
Wang, Li ;
Harrell, Frank E. ;
Yu, Chang ;
Robbins, Ivan M. ;
Newman, John H. ;
Hemnes, Anna R. .
PULMONARY CIRCULATION, 2016, 6 (03) :313-321
[4]   Pulmonary Hypertension Associated with Left-Sided Heart Disease [J].
Barnett, Christopher F. ;
De Marco, Teresa .
HEART FAILURE CLINICS, 2012, 8 (03) :447-+
[5]   Pulmonary Pressures and Death in Heart Failure A Community Study [J].
Bursi, Francesca ;
McNallan, Sheila M. ;
Redfield, Margaret M. ;
Nkomo, Vuyisile T. ;
Lam, Carolyn S. P. ;
Weston, Susan A. ;
Jiang, Ruoxiang ;
Roger, Veronique L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (03) :222-231
[6]   Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC [J].
Chen, X. ;
Zankl, A. ;
Niroomand, F. ;
Liu, Z. ;
Katus, H. A. ;
Jahn, L. ;
Tiefenbacher, C. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (01) :26-33
[7]   Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming [J].
D'Alessandro, Angelo ;
El Kasmi, Karim C. ;
Plecita-Hlavata, Lydie ;
Jezek, Petr ;
Li, Min ;
Zhang, Hui ;
Gupte, Sachin A. ;
Stenmark, Kurt R. .
ANTIOXIDANTS & REDOX SIGNALING, 2018, 28 (03) :230-250
[8]   Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure [J].
Delgado, JF ;
Conde, E ;
Sánchez, V ;
López-Rios, F ;
Gómez-Sánchez, MA ;
Escribano, P ;
Sotelo, T ;
de la Cámara, AG ;
Cortina, J ;
de la Calzada, CS .
EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (06) :1011-1016
[9]   STAR: ultrafast universal RNA-seq aligner [J].
Dobin, Alexander ;
Davis, Carrie A. ;
Schlesinger, Felix ;
Drenkow, Jorg ;
Zaleski, Chris ;
Jha, Sonali ;
Batut, Philippe ;
Chaisson, Mark ;
Gingeras, Thomas R. .
BIOINFORMATICS, 2013, 29 (01) :15-21
[10]   Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients [J].
Duarte, Julio D. ;
Kansal, Mayank ;
Desai, Ankit A. ;
Riden, Katherine ;
Arwood, Meghan J. ;
Yacob, Alex A. ;
Stamos, Thomas D. ;
Cavallari, Larisa H. ;
Zamanian, Roham T. ;
Shah, Sanjiv J. ;
Machado, Roberto F. .
PULMONARY CIRCULATION, 2018, 8 (02)